ClinicalTrials HQ

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Recruiting · NCT07259317 · Registry updated 2026-09-25
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaCarcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasmRecruitingPhase 22026-09-25NCT07259317

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Corcept Therapeutics9

20 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 01San AntonioUnited States2
Site 02ScottsdaleUnited States1
Site 03Grand RapidsUnited States1
Site 04Los AngelesUnited States1
Site 05Lake SuccessUnited States1
Site 06AtlantaUnited States1
Site 07ShirleyUnited States1
Site 08AlbanyUnited States1
Site 09NashvilleUnited States1
Site 10East BrunswickUnited States1
Site 11MorristownUnited States1
Site 12OrangeUnited States1
Site 13CincinnatiUnited States1
Site 14GoshenUnited States1
Site 15WestwoodUnited States1
Site 16Fort WorthUnited States1
Site 17JacksonvilleUnited States1
Site 18RochesterUnited States1
Site 19NashvilleUnited States1
Site 20ToledoUnited States1